News

SAN RAFAEL, Calif., (April 21, 2026) -- XDemics Corporation, a Caltech spin-out developing next- generation cultureware and bioreactor systems for biomedical research and therapeutic manufacturing, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,606,784.

Omios Biologics and XDemics Corporation have entered into a multi-year strategic collaboration to optimize the production of Omios' next-generation oncolytic virus (OV) therapeutics using XDemics' High-Density Cell Respiration™ (HDCR™) bioproduction platform.

SAN RAFAEL, Calif., (Feb. 12, 2026) -- XDemics Corporation, a Caltech spinout developing advanced cell production technologies, today announced that it has been awarded the 2026 SLAS Ignite Award at the SLAS International Conference and Exhibition in Boston.

SAN RAFAEL, Calif., (Jan. 16, 2026) -- XDemics Corporation, a Caltech spinout developing advanced cell production technologies, has signed a sales, distribution, and marketing agreement with VWR, part of Avantor (NYSE: AVTR), one of the world’s largest and most trusted laboratory supply networks.

SAN RAFAEL, Calif. – (August 8, 2025). Mr. Roush brings more than fifteen years of experience in corporate development, strategic partnerships, and M&A across life science tools and biotechnology.